Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary

Name: Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

When Health Canada authorizes a drug to be marketed in Canada, a Drug Identification Number (DIN) is issued to the manufacturer and printed on the package labels. A DIN indicates that the evaluation of the drug determined that it met the relevant requirements of the Food and Drugs Act and its regulations and the drug has a favourable risk/benefit profile. Manufacturers of prescription and non-prescription drugs must obtain a DIN before they are marketed in Canada

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2021-07-06

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary (English, HTML) HTML
Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary (French, HTML) HTML

Related open data

Health Canada